How many drugs treat Iron deficiency anemia?

Drug Landscape tracks 10 marketed treatments for Iron deficiency anemia (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/iron-deficiency-anemia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Iron deficiency anemia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Iron deficiency anemia (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Iron deficiency anemia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Monoferric	FERRIC DERISOMALTOSE	Pharmacosmos		Serotransferrin	2020-01-01
Accrufer	FERRIC MALTOL	Shield Tx			2019-01-01
Auryxia	FERRIC CITRATE	Keryx Biopharms	ferric citrate		2014-01-01
Injectafer	FERRIC CARBOXYMALTOSE	Am Regent			2013-01-01
Feraheme	FERUMOXYTOL	Covis	Parenteral Iron Replacement [EPC]		2009-01-01
Glucoferron	FERROUS GLUCONATE	Sanofi	Vitamin C [EPC]		1999-01-01
Iron Fumarate	FERROUS FUMARATE	Pfizer	Vitamin C [EPC]		1986-01-01
Cyanocobalamin Co 57	cyanocobalamin (57Co)	Mallinckrodt	Radioactive Diagnostic Agent	Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial, Methionine synthase, Methionine synthase reductase	1968-01-01
Colace	docusate sodium	Generic (multiple manufacturers)	Stool softener (surfactant laxative)	N/A (surfactant mechanism)	1955-01-01
Folic Acid	FOLIC ACID	Pfizer	Vitamin C [EPC]	Thymidylate synthase	1946-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 5 drugs in Iron deficiency anemia
Pfizer · 3 drugs in Iron deficiency anemia
Asan Medical Center · 1 drug in Iron deficiency anemia
Brigham and Women's Hospital · 1 drug in Iron deficiency anemia
Covis · 1 drug in Iron deficiency anemia
Generic (multiple manufacturers) · 1 drug in Iron deficiency anemia
Hippocration General Hospital · 1 drug in Iron deficiency anemia
Keryx Biopharms · 1 drug in Iron deficiency anemia
Mallinckrodt · 1 drug in Iron deficiency anemia
Pharmacosmos · 1 drug in Iron deficiency anemia
Sanofi · 1 drug in Iron deficiency anemia
Shield Tx · 1 drug in Iron deficiency anemia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Iron deficiency anemia:

Cite this brief

Drug Landscape (2026). Iron deficiency anemia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/iron-deficiency-anemia. Accessed 2026-06-10.

Iron deficiency anemia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing